Himax Technologies, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results; Provides First Quarter 2025 Guidance
February 13, 2025 05:10 ET
|
Himax Technologies, Inc.
Q4 2024 Revenues, Gross Margin and EPS All Surpassed Guidance Range Issued on November 7, 2024Company Q1 2025 Guidance: Revenues to Decrease 8.5% to 12.5% QoQ,Gross Margin is Expected to be Around...
atai Life Sciences Announces Pricing of Public Offering of Common Shares
February 12, 2025 22:47 ET
|
atai Life Sciences
NEW YORK and BERLIN, Feb. 12, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company focused on transforming the treatment of...
Euronet Reports Record Results Across All Financial Metrics For The Fourth Quarter And Full Year 2024
February 12, 2025 22:45 ET
|
Euronet Worldwide, Inc.
LEAWOOD, Kan., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Euronet (or the “Company”) (NASDAQ: EEFT), a global leader in payments processing and cross-border transactions, today announced fourth quarter and...
Aardvark Therapeutics Announces Pricing of Initial Public Offering
February 12, 2025 22:38 ET
|
Aardvark Therapeutics, Inc.
SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule...
Ponce De Leon Foundation Grant Awarded in the Amount of $610,000 to Nonprofits
February 12, 2025 17:52 ET
|
Ponce Financial Group, Inc.
BRONX, N.Y., Feb. 12, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of the Ponce De Leon Foundation is pleased to announce it has awarded $610,000 to nonprofits that are making a difference in our...
MGO Global Issues Reminder for Special Meeting of Stockholders to Vote on Approval of Business Combination Agreement with Heidmar
February 12, 2025 17:35 ET
|
MGO Global Inc.
MIAMI — LONDON, U.K. — ATHENS, Greece, Feb. 12, 2025 (GLOBE NEWSWIRE) -- MGO Global Inc. (Nasdaq: MGOL), a digitally-native, lifestyle brand portfolio company, (“MGO,” "MGO Global” or the...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
February 12, 2025 17:30 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and...
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 12, 2025 17:30 ET
|
Travere Therapeutics, Inc.
SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on February 10, 2025, the Compensation Committee of its Board of Directors granted...
Artius II Acquisition Inc. Announces Pricing of $200 Million Initial Public Offering
February 12, 2025 17:15 ET
|
Artius II Acquisition Inc.
Artius II Acquisition Inc. Announces Pricing of $200 Million Initial Public Offering
Oportun Reports Fourth Quarter and Full Year 2024 Financial Results
February 12, 2025 16:49 ET
|
Oportun Financial Corporation
Returned to GAAP profitability with net income of $9 million in fourth quarter Adjusted EBITDA of $41 million, up 315% year-over-year Quarterly annualized net charge-off rate of 11.7%, lowest since...